MADISON ODOM: Open Payments
NPI 1851949416 · KENNESAW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 17 payments from 8 companies in 2025. Trend: 2023 $754 · 2024 $529 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $183 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| ABBVIE INC. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: Ozempic, Wegovy, FARXIGA, Auvelity, TRELEGY ELLIPTA, QULIPTA, NURTEC ODT, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
